ICD E74.0ORPHA:365GSD-II

Pompe Disease

Pompe disease is a rare genetic condition where glycogen builds up in cells because of a missing enzyme, causing progressive muscle weakness affecting the heart, limbs, and breathing. Enzyme replacement therapy has transformed outcomes, particularly for infants diagnosed through newborn screening.

578
Articles
106
Trials (10 AU)
Updated
25 March 2026
Loading...

Common Questions

What is Pompe Disease?

Pompe disease is a rare genetic condition where glycogen builds up in cells because of a missing enzyme, causing progressive muscle weakness affecting the heart, limbs, and breathing. Enzyme replacement therapy has transformed outcomes, particularly for infants diagnosed through newborn screening.

How many clinical trials are available for Pompe Disease?

RareWays currently indexes 106 clinical trials for Pompe Disease, of which 20 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Pompe Disease come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Pompe Disease.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.